Skip to content

GLOBAL-E-CARE: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

GLOBAL-E-CARE

BE 0821.138.751
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€175,699
2024 · €125,263+€50,437
Equity
-€115,614
2024 · -€291,314+€175,699
Cash
€96,554
2024 · €86,053+€10,501
Balance sheet total
€1.4m
2024 · €1.5m-€36,997

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€55,979

    down €55,979 (-5.9%), from €945,524 to €889,545

    of which Land and buildings: -€58,002

Equity and liabilities
  • Profit (loss) carried forward +€175,699

    up €175,699 (+56.7%), from -€309,914 to -€134,214

  • Debts after one year -€165,953

    down €165,953 (-16.0%), from €1.0m to €873,239

  • Trade debts -€88,122

    down €88,122 (-31.6%), from €278,479 to €190,357

  • Current portion of long-term debt +€44,711

    up €44,711 (+27.4%), from €163,422 to €208,133

Income statement
  • Gross operating margin +€50,724

    up €50,724 (+8.6%), from €589,110 to €639,834

  • Staff costs +€17,018

    up €17,018 (+6.1%), from €279,075 to €296,094

  • Financial charges -€8,662

    down €8,662 (-8.2%), from €105,150 to €96,488

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €125,263
Gross operating margin +€50,724
Staff costs -€17,018
Depreciation +€2,892
Write-downs +€5,461
Other operating charges -€161
Financial income -€122
Financial charges +€8,662
Result 2025 €175,699

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€139,674
Investment -€7,931
Financing -€121,242
Cash 2024 €86,053
Net result for the year +€175,699
Depreciation +€63,910
Stocks and contracts -€969
Receivables within one year -€7,151
Deferred charges and accrued income -€362
Trade debts -€88,122
Tax, wage and social debts +€5,991
Other debts -€9,324
Investment in fixed assets (net) -€7,931
Debts after one year -€165,953
Current portion of long-term debt +€44,711
Cash 2025 €96,554
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,451,541 €1,414,544 -€36,997 -2.5%
Fixed assets 21/28 €945,524 €889,545 -€55,979 -5.9%
Tangible fixed assets 22/27 €945,524 €889,545 -€55,979 -5.9%
Land and buildings 22 €935,380 €877,378 -€58,002 -6.2%
Plant, machinery and equipment 23 €10,145 €12,167 +€2,023 +19.9%
Current assets 29/58 €506,017 €524,999 +€18,982 +3.8%
Stocks and contracts in progress 3 €276,223 €277,191 +€969 +0.4%
Stocks 30/36 €276,223 €277,191 +€969 +0.4%
Amounts receivable within one year 40/41 €141,171 €148,321 +€7,151 +5.1%
Trade receivables 40 €135,254 €141,003 +€5,749 +4.3%
Other amounts receivable 41 €5,917 €7,318 +€1,401 +23.7%
Cash at bank and in hand 54/58 €86,053 €96,554 +€10,501 +12.2%
Deferred charges and accrued income 490/1 €2,571 €2,933 +€362 +14.1%
Total equity and liabilities 10/49 €1,451,541 €1,414,544 -€36,997 -2.5%
Equity 10/15 -€291,314 -€115,614 +€175,699 +60.3%
Contributions 10/11 €18,600 €18,600 = 0.0%
Profit (loss) carried forward 14 -€309,914 -€134,214 +€175,699 +56.7%
Amounts payable 17/49 €1,742,855 €1,530,158 -€212,696 -12.2%
Amounts payable after more than one year 17 €1,039,191 €873,239 -€165,953 -16.0%
Financial debts 170/4 €1,039,191 €873,239 -€165,953 -16.0%
Amounts payable within one year 42/48 €703,663 €656,920 -€46,744 -6.6%
Current portion of amounts payable after more than one year 42 €163,422 €208,133 +€44,711 +27.4%
Trade debts 44 €278,479 €190,357 -€88,122 -31.6%
Suppliers 440/4 €278,479 €190,357 -€88,122 -31.6%
Taxes, remuneration and social security 45 €47,243 €53,235 +€5,991 +12.7%
Taxes 450/3 €2,686 €7,382 +€4,696 +174.8%
Remuneration and social security 454/9 €44,557 €45,852 +€1,295 +2.9%
Other amounts payable 47/48 €214,518 €205,195 -€9,324 -4.3%
Remuneration, social security and pensions 62 €279,075 €296,094 +€17,018 +6.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €66,801 €63,910 -€2,892 -4.3%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €6,346 €885 -€5,461 -86.1%
Other operating charges 640/8 €6,862 €7,023 +€161 +2.3%
Gross operating margin 9900 €589,110 €639,834 +€50,724 +8.6%
Operating profit (loss) 9901 €230,025 €271,923 +€41,897 +18.2%
Financial income 75/76B €387 €265 -€122 -31.6%
Recurring financial income 75 €387 €265 -€122 -31.6%
Financial charges 65/66B €105,150 €96,488 -€8,662 -8.2%
Recurring financial charges 65 €105,150 €96,488 -€8,662 -8.2%
Profit (loss) for the period before taxes 9903 €125,263 €175,699 +€50,437 +40.3%
Profit (loss) for the period 9904 €125,263 €175,699 +€50,437 +40.3%
Profit (loss) for the period to be appropriated 9905 €125,263 €175,699 +€50,437 +40.3%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.